Activity Description
This conversation between Dr. Marc Bloomenstein and Dr. Doug Devries explores the challenges and solutions in managing Meibomian Gland Dysfunction (MGD) in patients with high visual demands. The discussion covers diagnostic techniques, treatment options, and the importance of patient adherence to long-term management plans.
Accreditation
Sponsored by
The Fundingsland Group, LLC is a COPE-Approved Administrator.
This activity, COPE Activity Number 129011, is accredited by COPE for continuing education for optometrists. This course is approved for .25 hours of CE.
Course # 92702-TD
Activity #: 129011
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Release Date: 08-23-2024
Expiration Date: 08-23-2025
Grant Support Statement
This activity is supported by unrestricted educational grants from Alcon, Dompe, Harrow, Horizon Therapeutics, OCuSoft, SightSciences, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Inc. and Trukera.
Marc Bloomenstein, OD, FAAO
Director of Optometric Services
Doug Devries, OD
Director and Managing Partner